SECTOR:

Other therapeutics

FUND/VEHICLE:

Pivotal US; NFLS Direct Investment

INVESTMENT DATE:

2020

GEOGRAPHY:

North America

STATUS CURRENT/FORMER INVESTMENT:

Existing

WEBSITE:

Evommune is using the skin as the lens to uncover new approaches for accelerating the development of vital medicines across immunology and dermatology. Utilizing a novel screening platform, we identify molecules that are differentiated and that have a greater probability of being effective in treating patients